Cytogen 10K 2003 Annual report | SEC Filing

Cytogen Inactive 10-K2003 FY Annual report

Content analysis

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: abbreviated, abdominal, absence, abstract, Academy, accomplish, accomplished, accreted, accretion, actuarial, acute, affirmative, Alkeran, allogeneic, AMA, Amersham, amicable, analyst, ANDA, andJ, andqui, anin, Antisoma, appeal, applicationsincluding, Appln, Arizona, arrived, ArV, asqui, assumption, attended, attenuation, Aultman, awaiting, Bachelor, Baruch, Berkeley, bioequivalence, BMSMI, brain, brokerage, Brunswick, BS, BTAStat, budgetary, calcific, California, Cantanzaro, capromab, CBER, CDER, cellsin, chance, Chase, chemorefractory, chest, Chicago, chloride, christopher, Cleveland, climate, Clin, COBRA, Commerce, commercializeex, comparison, Condensed, conjugated, constrain, contamination, CORD, Council, CPA, CUNY, cytotoxic, dark, deemed, DePaul, deposition, destination, developin, Dickinson, died, dimensional, dimer, dimeric, disruption, distant, docetaxel, domestic, dosage, drafted, duration, EBRT, educate, elicited, Elizabethtown, Emcyt, emitting, energy, engineering, England, equivocal, estramustine, ethylenediaminetetramethylenephosphonic, excessive, exhausted, Fairleigh, ferumoxytol, Filtered, FIN, Finova, firm, fiscal, Flash, flat, Flexpaq, forefront, forex, forin, formally, frame, franchise, fraught, frustrate, fulfill, fulfilled, Gadolinium, gave, GE, Genaera, Genisphere, Gobern, graduate, Greer, grew, GSI, Hadassah, Hale, Harrisburg, Hawkeye, headquartered, healthy, hematologic, highlighted, histological, histopathologic, homodimer, Horoszewicz, hospital, Hummer, imply, Importantly, impossible, improper, inability, Indium, Infinia, inflammatory, influence, infrequent, infusion, injury, insert, installation, instance, invasion, invoiced, IRB, iron, Israel, Italy, iterative, JFK, joined, joining, Journal, journalBlood, journalRadiology, Kettering, lastly, lesser, leukemia, lexidronam, likelihood, linker, LNCaP, lymphatic, lymphotropic, Magainin, mandatorily, Maryland, maximum, MBA, MDS, Med, mediastinal, medium, Mellon, melphalan, Mentor, merge, Metro, MGH, middle, Millennium, minute, mirror, Missouri, modified, modifying, monomer, monomeric, monthly, myelodysplastic, myeloma, myelosuppression, naked, nanoparticle, necessarily, neck, Nijmegen, NJ, nodal, noncontrolling, noncreditable, nonprofit, nonrefundable, Nucl, occult, ofin, Oncol, open, opening, Oregon, outplacement, oxide, paclitaxel, page, palliation, Pat, pathology, pattern, payer, Pemtumomab, pendetide, periphery, permanent, persuasive, phosphate, Polyprobe, poorer, possessed, postmarket, pp, pre, predominantly, preferentially, proactively, promptly, pulsing, purpose, Putman, QUADRAMETTM, question, Radiochemistry, radioimmunoguided, radionuclide, rata, ratifying, realign, reconcile, reconstruction, recordkeeping, redeemable, referenced, referencing, refused, regimen, reinterpreted, relaxation, remote, reply, resection, residual, resistant, resolved, retrospective, revealed, rim, Rome, Rorer, route, rsPSMA, running, samarium, schnittker, Science, scientist, Scottsdale, sequential, Serial, Shareholder, singly, SKICR, Sloan, Soc, sodium, soluble, specialty, SPECT, stability, statutory, stem, stopped, substantive, substituted, superparamagnetic, Supervisor, supervisory, Suppl, suspected, Sweden, symptomatic, syndrome, Taxol, Taxotere, testicular, theInternational, theJ, theNew, theProc, thereon, toex, tolerated, toll, traditionally, transformational, transplant, transplantation, true, twelve, ultrasmall, Ultrasound, UMCN, Umea, unamortized, unapproved, UNC, unchanged, undergraduate, undermined, undetectable, unenhanced, unexpected, unsuccessful, USA, usage, VIE, virtue, visible, visit, visiting, vivoimmunotherapy, vivoprostate, vol, waiver, Washington, Waterhouse, Wayne, web, Western, wholly, wider, workstation, world, Wroxton, XenomouseTM, Yardley, zoledronic, Zometa

Removed: Acqua, adequately, affiliate, age, amplification, anticancer, array, assay, avoid, biochip, bringing, build, cancelled, capability, capped, Circle, clarifying, colon, competence, concentrate, concept, concurrent, consortium, consumer, CR, Crane, death, Dec, dedicated, deferral, digital, discovered, division, Donald, efficient, employing, enforceability, exempt, fit, forma, forward, Gas, handled, Imputed, increasingly, INDEX, intention, invaded, ix, liquid, Matching, medically, Merck, NCCN, negotiated, Noncompliance, Notwithstanding, Novantrone, objective, partnering, payroll, pharmacokinetic, piggyback, plasma, practical, predictability, priority, proof, publicity, reached, recommended, recurred, register, retention, rheumatoid, Rolling, satisfactorily, sensitive, Sept, shipment, source, step, Supplementary, ultimate, unregistered, urologic, urological, user, view, volatility, Vote, Wellington

Dated: March 15, 2004

/s/ Christopher P. Schnittker

Christopher P. Schnittker
Vice President and Chief Financial Officer